NEWS
2022-2024
Israel Innovation Authority
Bio-convergence grant award
Developing novel cannabinoid-based analgesics: targeting the pain receptors TRPV1 and TRPA1
רשות החדשנות
Israel Innovation Authority
2019 - 2020
Contract signed with Scopus Biopharma (about Scopus)
The Scopus Biopharma company funded the conduct of a feasibility study for the development of protocols for synthesis of new CBD derivatives.
Multidisciplinary Center for Cannabinoid Research
2021 - 2022
Contract signed with Clearmind Medicine Inc.
Psychedelic drug development company Clearmind Medicine Inc. will fund a study for development of novel psychedelic drugs. ( about Clearmind)
Clearmind
Psychedelic Drug Company
2018-2022
Israel Science Foundation (ISF) grant award
The research funds were awarded for the period of 2018-2022. Project: Stretching the Model of TRPV1 Activation.
Israel Science Foundation (ISF)
2021 - 2022
Israel Innovation Authority
Bio-convergence grant award
The research funds were awarded for the period of 2021-22. Project: Development of Novel Neurotropic Drug for Polyneuropathy.
רשות החדשנות
Israel Innovation Authority
2017 - 2018
"Nofar" Ministry of Science and Industry grant awarded
The research funds were awarded for the period of 2017-18. Project: Novel Synthetic Scaffold DT100 Promotes Silencing of the Pain Receptor TRPV1.
Ministry of Economy and Industry
2014 - 2018
Volkswagen Stiftung grant award
Structure Pattern Recognition: A Catalyst for Methodology Development in Total Synthesis. Cooperation Lower Saxony - Israel.
Volkswagen Foundation
